Ulcerative colitis: open trials in South Africa

4 open trials have a site in South Africa. Registry data; only the trial team decides who can take part.

NCT07158242
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Hoffmann-La Roche
IATROS International, Bloemfontein · Emmed Research, Pretoria
Registry updated 2026-11-05
NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly and Company
IATROS International, Bloemfontein · Spoke Research, Cape Town · Mediclinic Panorama, Cape Town · Lenasia Clinical Trial Centre - Johannesburg, Johannesburg · Clinresco Centres, Kempton Park
Registry updated 2026-11-04
NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Claremont · Durban · Kempton Park
Registry updated 2026-10-23
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Cape Town · Claremont · Durban
Registry updated 2026-10-16

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis